Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Understand the key risks the SP 500 presents to retirees and how volatility can impact withdrawal plans and long-term goals. This intro covers market exposure and practical safeguards.
17,139 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A fresh Mizuho note raises Intel's price target to $124 on AI server demand, signaling renewed confidence in the turn...
Great Elm's Q3 2026 earnings shed light on growth, margins, and capital allocation. This article breaks down the numb...
Solana is trading near $97 as traders weigh a potential move above $100 this month. Analysts point to ETF demand and ...
Institutional investors are loading up on two beaten-down software giants as AI infrastructure demand remains solid a...
Costco emerges as a steadier bet than meme-driven plays, backed by membership cash flow and a durable dividend path. ...
Q1 2026 dumped new data on the health tech landscape, revealing who’s thriving, where margins are headed, and how to ...
May brings optimism for growth investors. In this guide, I share my favorite growth stocks to buy in May, why they fi...
A surprising uptick in the memory sector has traders asking, 'Why is SanDisk stock today?' While SanDisk isn’t traded...
When Brookfield Corporation just reported, investors want clarity on cash flow, debt, and capital allocation. This gu...
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Space excitement can push stocks higher fast, but gains often fade without lasting fundamentals. Here’s a practical g...